Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado”

401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 401
Index total 30,257
Page 12 / 17

Quick answer

This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

401 results for “The Regents of the University of Colorado” · 30,257 patents in full index Clear search

  1. US 8911722

    Modulation of yeast-based immunotherapy products and responses

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  2. US 8883948

    Methods for extensive dark curing based on visible-light initiated, controlled radical polymerization

    The Regents of the University of Colorado · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  3. US 8883144

    Treatment of pulmonary vascular remodeling with neprilysin

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  4. US 8883507

    Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cells

    The Regents of the University of Colorado · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  5. US 8883189

    Intraocular encapsulation of oxygenic bacteria

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  6. US 8859716

    Degradable thiol-ene polymers

    The Regents of the University of Colorado · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  7. US 8858945

    Three-dimensional structure of complement receptor type 2 and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  8. US 8840905

    Use of neurotoxin therapy for treatment of urologic and related disorders

    The Regents of the University of Colorado · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  9. US 8840868

    Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  10. US 8816046

    Compositions and methods for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  11. US 8808710

    Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  12. US 8796438

    Nucleic acids encoding inactive variants of human telomerase

    The Regents of the University of Colorado · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  13. US 8754050

    Macrocyclic compounds useful as inhibitors of histone deacetylases

    The Regents of the University of Colorado · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  14. US 8735358

    Methods for treating cancer by regulation of tumor necrosis factor-alpha

    The Regents of the University of Colorado, a Body Corporate · Granted May 27, 2014 · Expires May 22, 2034

    granted

  15. US 8734778

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted May 27, 2014 · Expires May 22, 2034

    granted

  16. US 8727775

    Dimer acid-derived dimethacrylates and use in dental restorative compositions

    The Regents of the University of Colorado, a Body Corporate · Granted May 20, 2014 · Expires May 15, 2034

    granted

  17. US 8725266

    Method for stimulating retinal response using photoactive devices

    The Regents of the University of Colorado, a Body Corporate · Granted May 13, 2014 · Expires May 8, 2034

    granted

  18. US 8715649

    Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity

    The Regents of the University of Colorado, a Body Corporate · Granted May 6, 2014 · Expires May 1, 2034

    granted

  19. US 8715645

    Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same

    The Regents of the University of Colorado · Granted May 6, 2014 · Expires May 1, 2034

    granted

  20. US 8709995

    Method for eliciting an immune response to human telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  21. US 8703140

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  22. US 8697628

    Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  23. US 8697848

    Method for reducing immunogenicity of therapeutic protein compositions

    The Regents of the University of Colorado · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  24. US 8685926

    Compositions and method for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.